Médecins Sans Frontières, Kinshasa, Democratic Republic of Congo.
Médecins Sans Frontières, Conakry, Guinea.
BMC Infect Dis. 2020 Oct 7;20(1):734. doi: 10.1186/s12879-020-05470-0.
HIV continues to be the main determinant morbidity with high mortality rates in Sub-Saharan Africa, with a high number of patients being late presenters with advanced HIV. Clinical management of advanced HIV patients is thus complex and requires strict adherence to updated, empirical and simplified guidelines. The current study investigated the impact of the implementation of a new clinical guideline on the management of advanced HIV in Kinshasa, Democratic Republic of Congo (DRC).
A retrospective analysis of routine clinical data of advanced HIV patients was conducted for the periods; February 2016 to March 2017, before implementation of new guidelines, and November 2017 to July 2018, after the implementation of new guidelines. Eligible patients were patients with CD4 < 200 cell/μl and presenting with at least 1 of 4 opportunistic infections. Patient files were reviewed by a medical doctor and a committee of 3 other doctors for congruence. Statistical significance was set at 0.05%.
Two hundred four and Two hundred thirty-one patients were eligible for inclusion before and after the implementation of new guidelines respectively. Sex and age distributions were similar for both periods, and median CD4 were 36 & 52 cell/μl, before and after the new guidelines implementation, respectively. 40.7% of patients had at least 1 missed/incorrect diagnosis before the new guidelines compared to 30% after new guidelines, p < 0.05. Clinical diagnosis for TB and toxoplasmosis were also much improved after the implementation of new guidelines. In addition, only 63% of patients had CD4 count test results before the new guidelines compared to 99% of patients after new guidelines. Death odds after the implementation of new guidelines were significantly lower than before new guidelines in a multivariate regression model that included patients CD4 count and 10 other covariates, p < 0.05.
Simplification and implementation of a new and improved HIV clinical guideline coupled with the installation of laboratory equipment and point of care tests potentially helped reduce incorrect diagnosis and improve clinical outcomes of patients with advanced HIV. Regulating authorities should consider developing simplified versions of guidelines followed by the provision of basic diagnostic equipment to health centers.
艾滋病毒仍然是撒哈拉以南非洲地区发病率的主要决定因素,死亡率很高,大量患者出现晚期症状,且艾滋病毒状况严重。因此,晚期艾滋病毒患者的临床管理非常复杂,需要严格遵守最新的、经验性的和简化的指南。本研究调查了在刚果民主共和国金沙萨实施新临床指南对晚期艾滋病毒管理的影响。
对 2016 年 2 月至 2017 年 3 月(新指南实施前)和 2017 年 11 月至 2018 年 7 月(新指南实施后)期间符合条件的晚期艾滋病毒患者的常规临床数据进行回顾性分析。符合条件的患者为 CD4<200 个细胞/μl,至少有 4 种机会性感染中的 1 种。由一名医生和另外三名医生组成的委员会对患者病历进行审查,以确保一致性。统计显著性设定为 0.05%。
在新指南实施前后,分别有 204 名和 231 名患者符合纳入标准。两个时期的性别和年龄分布相似,新指南实施前后的中位数 CD4 分别为 36 和 52 个细胞/μl。新指南实施前,40.7%的患者至少有 1 次漏诊/误诊,而新指南实施后,这一比例为 30%,p<0.05。TB 和弓形体病的临床诊断也在新指南实施后得到了很大改善。此外,新指南实施前只有 63%的患者进行了 CD4 计数检测,而新指南实施后,这一比例为 99%。在包含患者 CD4 计数和其他 10 个协变量的多变量回归模型中,新指南实施后的死亡风险明显低于新指南实施前,p<0.05。
简化和实施新的、改进的艾滋病毒临床指南,再加上实验室设备和即时检测的安装,可能有助于减少错误诊断,改善晚期艾滋病毒患者的临床结局。监管机构应考虑制定简化版指南,并为卫生中心提供基本诊断设备。